Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
BAILLIE GIFFORD & CO SANA Sana Biotechnology, Inc. 13G/A 5.15% 2y
BAILLIE GIFFORD & CO ODD Oddity Tech Ltd 13G/A 12.97% 2y
BAILLIE GIFFORD & CO STAA Staar Surgical Co 13G/A 9.11% 2y
BAILLIE GIFFORD & CO NIO NIO Inc. 13G/A 5.97% 2y
BAILLIE GIFFORD & CO SE Sea Ltd 13G 6.56% 2y
Tao Liu CPHI China Pharma Holdings, Inc. 13G 27.3% 2y
Lepercq De Neuflize Asset Management LLC BLPH Bellerophon Therapeutics, Inc. 13G 8.4% 2y
Yakira Capital Management, Inc. ALSAF Alpha Star Acquisition Corp 13G/A 5.14% 2y
Yakira Capital Management, Inc. AOGO Arogo Capital Acquisition Corp. Class A Common Stock 13G/A 0% 2y
Yakira Capital Management, Inc. MACA Moringa Acquisition Corp Class A Ordinary Shares 13G 5.21% 2y
Yakira Capital Management, Inc. IRRX Integrated Rail and Resources Acquisition Corp. 13G 5.64% 2y
Yakira Capital Management, Inc. BITE Bite Acquisition Corp. 13G 5.46% 2y
BROWN BROTHERS HARRIMAN & CO WEST Westrock Coffee Co 13G/A 19% 2y
Yakira Capital Management, Inc. ELIQ Electriq Power Holdings, Inc. 13G/A 0.02% 2y
Yakira Capital Management, Inc. ECDA ECD Automotive Design, Inc. 13G/A 0% 2y
Yakira Capital Management, Inc. MAQC Maquia Capital Acquisition Corporation Class A Common Stock 13G/A 0% 2y
Yakira Capital Management, Inc. FRLA Fortune Rise Acquisition Corporation Class A Common Stock 13G/A 6.05% 2y
Yakira Capital Management, Inc. CLRCF ClimateRock 13G 5.52% 2y
Yakira Capital Management, Inc. LIBY Liberty Resources Acquisition Corp. Class A Common Stock 13G 7.17% 2y
Yakira Capital Management, Inc. FATP Fat Projects Acquisition Corp Class A Ordinary Share 13G/A 0% 2y
Yakira Capital Management, Inc. IGTA Inception Growth Acquisition Ltd 13G/A 0% 2y
Yakira Capital Management, Inc. EMAT Evolution Metals & Technologies Corp. 13G 6.26% 2y
The Gabriel 613 Trust CRGE Charge Enterprises, Inc. Common Stock 13G 14.5% 2y
Ellis Donald Douglas JR ZNOG Zion Oil & Gas Inc 13G 7.94% 2y
DRIMAL CHARLES E JR PNRG Primeenergy Resources Corp 13D/A 48.5% 2y
TAKEDA PHARMACEUTICAL CO LTD PHAT Phathom Pharmaceuticals, Inc. 13D/A 6.6% 2y
Antofagasta plc BVN Buenaventura Mining Co Inc 13D/A 18.9% 2y
Jan K. Smeets PNRG Primeenergy Resources Corp 13D/A 4.91% 2y
venBio Global Strategic Fund III, L.P. PHVS Pharvaris N.V. 13D/A 8.4% 2y
Point72 Asset Management, L.P. FATE Fate Therapeutics Inc 13G 5% 2y
James N. Topper ORIC Oric Pharmaceuticals, Inc. 13G 6.2% 2y
Amster Howard WHLR Wheeler Real Estate Investment Trust, Inc. 13D/A 9.01% 2y
Harraden Circle Investments, LLC GMFI Aetherium Acquisition Corp. Class A Common Stock 13G 9.93% 2y
Abel Avellan ASTS AST SpaceMobile, Inc. 13D/A 38.9% 2y
Atlas Venture Fund X, L.P. IRON Disc Medicine, Inc. 13D/A 5.8% 2y
BOXER CAPITAL, LLC MRTX Mirati Therapeutics, Inc. Common Stock 13D/A 0% 2y
ORBIMED ADVISORS LLC EWTX Edgewise Therapeutics, Inc. 13D/A 17.3% 2y
NOVO HOLDINGS A/S EWTX Edgewise Therapeutics, Inc. 13D/A 7.4% 2y
MILTON C. AULT, III ALZN Alzamend Neuro, Inc. 13D/A 29.4% 2y
Magnetar Financial LLC CMTL Comtech Telecommunications Corp 13D/A 36.64% 2y
Titanite Investment Management LP NSTG NanoString Technologies, Inc. 13G/A 3.7% 2y
First Trust Capital Management L.P. PSBD Palmer Square Capital BDC Inc. 13G 6.52% 2y
Orin Hirschman TGAN Transphorm, Inc. Common Stock 13G/A 2% 2y
Millennium Management LLC TERN Terns Pharmaceuticals, Inc. 13G 5.6% 2y
Warlock Partners, LLC PAAI Paradium.AI, Inc. 13D 6.3% 2y
Sculptor Capital LP TCOA Zalatoris Acquisition Corp. 13G 9.24% 2y
BlackRock Inc. AMP Ameriprise Financial Inc 13G/A 8.2% 2y
BlackRock Inc. WEX WEX Inc. 13G/A 9% 2y
BlackRock Inc. DTE Dte Energy Co 13G/A 8.4% 2y
BlackRock Inc. FARO Faro Technologies Inc 13G/A 8.1% 2y